Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADAPT N-of-1 trial of psychotropic drugs for agitation in dementia
NL-OMON60926Phase 4Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of quetiapine, olanzapine and lorazepam in Dementia, sponsored by Amsterdam University Medical Center. Started Jul 2025; status: recruiting.
02
Drugs
quetiapineolanzapinelorazepam
03
Conditions
Dementia
Beyond the preview
Go deeper on NL-OMON60926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60926.